TP53 GENE MUTATION

Clinical trials for TP53 GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new TP53 GENE MUTATION trials appear

Sign up with your email to follow new studies for TP53 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Not yet finished but already full! 1

New Vaccine-Immunotherapy combo targets multiple cancers in early trial

Disease control Ongoing

This phase 1 trial tests a vaccine (p53MVA) that trains the immune system to attack cancer cells with a p53 mutation, given together with the immunotherapy drug pembrolizumab (Keytruda). The study includes 11 people with advanced solid tumors like lung, head and neck, liver, kidn…

Matched conditions: TP53 GENE MUTATION

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

TP53 GENE MUTATION

Get alerted when new TP53 GENE MUTATION trials appear

New Vaccine-Immunotherapy combo targets multiple cancers in early trial